Feb 12 (Reuters) - BridgeBio Pharma said on Thursday its experimental therapy boosted growth rates in children with a rare ...
Feb 12 (Reuters) - BridgeBio Pharma said its experimental therapy boosted growth rates in children with a rare genetic ...
SAN FRANCISCO, Feb 11 (Reuters) - Some pharmaceutical companies not targeted by President Donald Trump for agreements to ...
Zacks.com on MSN
HudBay Minerals (HBM) Earnings Expected to Grow: Should You Buy?
The market expects HudBay Minerals (HBM) to deliver a year-over-year increase in earnings on higher revenues when it reports ...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the most promising future stocks to buy now. Piper Sandler revised the ...
The latest update is out from BioMarin Pharmaceutical ( (BMRN) ).
The rare disease drugmaker is facing potential competitors for achondroplasia drug Voxzogo. Is a big M&A deal with two ...
There's no need to hurry in buying this biotech stock.
BioMarin Pharmaceutical (NASDAQ:BMRN) and Ascendis Pharma (NASDAQ:ASND) stocks dropped approximately 6% following the release ...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the Best Cheap Stocks to Buy Right Now. Barclays initiated coverage of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results